The Lancet · 18 Sept 2026 · Review

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Rebbeck

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population.
The Lancet Oncology · 1 Oct 2026 · Review
Expanding cancer susceptibility testing to the general population requires careful evaluation of clinical and public health benefits, with evidence supporting its use mainly for well-established genes.
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790443
Open in JClub
Ethical priorities in global cancer genomics and precision oncology.
The Lancet Oncology · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790440
Open in JClub
Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.
The Lancet Oncology · 1 Oct 2026 · Review
Access to cancer genomics and precision oncology remains profoundly unequal worldwide, limiting benefits for millions of patients and hindering research progress.
- 10 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790448
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read